An Investigational Study of MK0928 in Adult Outpatients With Insomnia (0928-014)(COMPLETED)

• Status: Completed
• Trial end date: 2006-10-01
• Target enrollment: 0
• Participant gender: All

Summary

The purpose of this study is to evaluate the safety and effectiveness of MK0928 for insomnia (a sleep disorder).

• Phase: Phase 3
• Accepts Healthy Volunteers?: No

Details

• Lead Sponsor: H. Lundbeck A/S
• Treatments: Gaboxadol

Criteria

Inclusion Criteria:

• Adult outpatients who are between the ages of 18 and 64

Exclusion Criteria:

• Adults who do not have a diagnosis of insomnia (a sleep disorder)